TRMCX
Price
$36.17
Change
-$0.17 (-0.47%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

TRMCX vs VMVAX

Header iconTRMCX vs VMVAX Comparison
Open Charts TRMCX vs VMVAXBanner chart's image
T. Rowe Price Mid-Cap Value
Price$36.17
Change-$0.17 (-0.47%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
TRMCX vs VMVAX Comparison Chart
Loading...
VS
TRMCX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRMCX is a Buy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. TRMCX (15.9B). VMVAX pays higher dividends than TRMCX: VMVAX (2.14) vs TRMCX (0.97). TRMCX was incepted earlier than VMVAX: TRMCX (28 years) vs VMVAX (13 years). TRMCX is a more actively managed with annual turnover of: 45.30 vs. VMVAX (22.00). TRMCX has a lower initial minimum investment than VMVAX: TRMCX (2500) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. TRMCX (21.77). VMVAX return over 5 years is better than : 48.82 vs. TRMCX (38.12).
TRMCXVMVAXTRMCX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years13 years-
Gain YTD15.92914.946107%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets15.9B30.5B52%
Annual Yield % from dividends0.972.1445%
Returns for 1 year21.7725.3586%
Returns for 3 years10.4520.7150%
Returns for 5 years38.1248.8278%
Returns for 10 years20.20100.8820%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio